GSK-204948

Study Sponsor: GSK

Study Title

A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with urinary incontinence due to neurogenic detrusor overactivity

Medicine or Vaccine (generic name)

OnabotulinumtoxinA

Sponsor Identification Number

204948

Trial Registry Identification Number(#'s)

NCT02849418

Medical Condition

Urinary Bladder, Overactive

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204948

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02849418

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2021